Structures by: Monfared H. H.
Total: 7
C21H17CuN3O5,C2H6O,H2O
C21H17CuN3O5,C2H6O,H2O
Dalton transactions (Cambridge, England : 2003) (2011) 40, 6 1286-1294
a=13.6380(3)Å b=23.6172(5)Å c=7.24590(10)Å
α=90.00° β=96.1919(12)° γ=90.00°
C21H17CuN3O5
C21H17CuN3O5
Dalton transactions (Cambridge, England : 2003) (2011) 40, 6 1286-1294
a=4.7333(3)Å b=16.0520(10)Å c=24.2371(10)Å
α=90.00° β=94.195(5)° γ=90.00°
Salicylaldehyde thiosemicarbazone 0.17hydrate; (E)-2-(2- hydroxybenzylidene)hydrazinecarbothioamide 0.17hydrate
C8H9N3OS,0.17(H2O)
CrystEngComm (2010) 12, 11 3526
a=13.7595(6)Å b=14.2594(6)Å c=10.4876(4)Å
α=90.00° β=115.3670(10)° γ=90.00°
Salicylaldehyde thiosemicarbazone 0.17hydrate; (E)-2-(2-hydroxybenzylidene)hydrazinecarbothioamide 0.095hydrate
C8H9N3OS,0.095(H2O)
CrystEngComm (2010) 12, 11 3526
a=13.9737(4)Å b=14.2331(4)Å c=10.4655(2)Å
α=90.00° β=115.781(2)° γ=90.00°
Salicylaldehyde thiosemicarbazone 0.20hydrate; (E)-2-(2-hydroxybenzylidene)hydrazinecarbothioamide 0.20hydrate
C8H9N3OS,0.2(H2O)
CrystEngComm (2010) 12, 11 3526
a=13.8383(16)Å b=14.3405(17)Å c=10.5113(12)Å
α=90.00° β=114.986(4)° γ=90.00°
(<i>E</i>)-3-Hydroxy-<i>N</i>'-(2-hydroxybenzylidene)-2-naphthohydrazide
C18H14N2O3
Acta Crystallographica Section E (2010) 66, 1 o236-o237
a=12.6749(4)Å b=4.96660(10)Å c=22.7299(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-4-Hydroxy-<i>N</i>'-(2-hydroxy-5-iodobenzylidene)benzohydrazide methanol monosolvate
C14H11IN2O3,CH4O
Acta Crystallographica Section E (2012) 68, 9 o2698
a=10.1077(7)Å b=12.5703(11)Å c=13.1586(17)Å
α=90.00° β=102.886(10)° γ=90.00°